Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach makes remarks on the issues of safety, innovation and globalization facing the FDA at the Reuters Regulation Summit in Washington February 5, 2008. REUTERS/Mike Theiler (UNITED STATES)